Concepts (321)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 38 | 2025 | 352 | 6.130 |
Why?
|
| Cognition Disorders | 35 | 2017 | 237 | 4.480 |
Why?
|
| Cognition | 42 | 2019 | 337 | 4.380 |
Why?
|
| Cognitive Dysfunction | 25 | 2025 | 235 | 4.350 |
Why?
|
| Alzheimer Disease | 38 | 2025 | 409 | 3.500 |
Why?
|
| Aged | 101 | 2025 | 1860 | 3.220 |
Why?
|
| Aged, 80 and over | 79 | 2025 | 1034 | 2.990 |
Why?
|
| Male | 108 | 2025 | 3399 | 2.850 |
Why?
|
| Female | 107 | 2025 | 3346 | 2.840 |
Why?
|
| Brain | 23 | 2020 | 331 | 2.800 |
Why?
|
| Longitudinal Studies | 51 | 2025 | 363 | 2.580 |
Why?
|
| Dementia | 14 | 2021 | 127 | 2.560 |
Why?
|
| Humans | 112 | 2025 | 5837 | 2.360 |
Why?
|
| Neuropsychological Tests | 32 | 2019 | 309 | 1.770 |
Why?
|
| DNA-Binding Proteins | 7 | 2019 | 94 | 1.420 |
Why?
|
| Depression | 8 | 2016 | 113 | 1.270 |
Why?
|
| Memory, Episodic | 3 | 2019 | 26 | 1.210 |
Why?
|
| Lewy Bodies | 6 | 2019 | 56 | 1.150 |
Why?
|
| Neurodegenerative Diseases | 3 | 2018 | 39 | 1.090 |
Why?
|
| Cognitive Aging | 5 | 2018 | 27 | 1.030 |
Why?
|
| Hospitalization | 3 | 2019 | 86 | 1.010 |
Why?
|
| Disease Progression | 12 | 2019 | 157 | 0.990 |
Why?
|
| Memory | 8 | 2016 | 61 | 0.980 |
Why?
|
| Loneliness | 6 | 2025 | 22 | 0.950 |
Why?
|
| Chicago | 18 | 2025 | 239 | 0.950 |
Why?
|
| Apolipoprotein E4 | 12 | 2025 | 92 | 0.910 |
Why?
|
| Follow-Up Studies | 19 | 2017 | 333 | 0.850 |
Why?
|
| Risk Factors | 29 | 2021 | 499 | 0.820 |
Why?
|
| Perception | 4 | 2021 | 30 | 0.810 |
Why?
|
| Cohort Studies | 20 | 2024 | 406 | 0.800 |
Why?
|
| Olfaction Disorders | 3 | 2016 | 8 | 0.780 |
Why?
|
| Middle Aged | 20 | 2021 | 1775 | 0.770 |
Why?
|
| Health Literacy | 3 | 2019 | 28 | 0.730 |
Why?
|
| Personality | 3 | 2015 | 14 | 0.730 |
Why?
|
| Hippocampus | 3 | 2019 | 61 | 0.720 |
Why?
|
| Geriatric Assessment | 13 | 2017 | 59 | 0.700 |
Why?
|
| Interpersonal Relations | 3 | 2014 | 26 | 0.680 |
Why?
|
| Neurofibrillary Tangles | 5 | 2017 | 33 | 0.680 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2017 | 123 | 0.630 |
Why?
|
| Memory, Short-Term | 2 | 2019 | 37 | 0.610 |
Why?
|
| Language | 2 | 2010 | 15 | 0.570 |
Why?
|
| Memory Disorders | 2 | 2017 | 48 | 0.560 |
Why?
|
| Learning | 1 | 2018 | 23 | 0.540 |
Why?
|
| Mortality | 4 | 2016 | 22 | 0.530 |
Why?
|
| Motor Activity | 7 | 2015 | 83 | 0.530 |
Why?
|
| Reading | 2 | 2021 | 9 | 0.520 |
Why?
|
| Ambulatory Care | 1 | 2017 | 16 | 0.520 |
Why?
|
| Chronic Disease | 1 | 2017 | 71 | 0.510 |
Why?
|
| Apolipoproteins E | 7 | 2017 | 55 | 0.500 |
Why?
|
| Amyloid beta-Peptides | 2 | 2017 | 41 | 0.500 |
Why?
|
| Stress, Psychological | 5 | 2021 | 58 | 0.500 |
Why?
|
| Agnosia | 1 | 2016 | 3 | 0.490 |
Why?
|
| Brain Chemistry | 1 | 2016 | 11 | 0.470 |
Why?
|
| United States | 14 | 2020 | 502 | 0.470 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 35 | 0.470 |
Why?
|
| Urban Population | 3 | 2013 | 34 | 0.470 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 28 | 0.470 |
Why?
|
| Neurons | 2 | 2013 | 90 | 0.460 |
Why?
|
| Independent Living | 6 | 2025 | 62 | 0.450 |
Why?
|
| Educational Status | 7 | 2021 | 60 | 0.440 |
Why?
|
| Activities of Daily Living | 5 | 2013 | 75 | 0.430 |
Why?
|
| Autopsy | 7 | 2020 | 67 | 0.430 |
Why?
|
| Parkinsonian Disorders | 4 | 2017 | 43 | 0.410 |
Why?
|
| Mesencephalon | 1 | 2013 | 11 | 0.410 |
Why?
|
| Proportional Hazards Models | 9 | 2017 | 71 | 0.400 |
Why?
|
| Lewy Body Disease | 3 | 2018 | 29 | 0.390 |
Why?
|
| Decision Making | 4 | 2021 | 49 | 0.390 |
Why?
|
| Age Factors | 9 | 2016 | 181 | 0.380 |
Why?
|
| Membrane Transport Proteins | 3 | 2017 | 29 | 0.380 |
Why?
|
| Risk | 10 | 2018 | 60 | 0.370 |
Why?
|
| Motor Skills | 1 | 2012 | 8 | 0.370 |
Why?
|
| Family | 3 | 2021 | 26 | 0.360 |
Why?
|
| Prospective Studies | 14 | 2025 | 411 | 0.360 |
Why?
|
| Diet | 4 | 2010 | 54 | 0.350 |
Why?
|
| Incidence | 12 | 2025 | 165 | 0.340 |
Why?
|
| Odorants | 1 | 2010 | 5 | 0.330 |
Why?
|
| Knowledge | 1 | 2010 | 6 | 0.330 |
Why?
|
| Stroke | 3 | 2016 | 71 | 0.320 |
Why?
|
| Social Isolation | 3 | 2025 | 9 | 0.320 |
Why?
|
| Parkinson Disease | 4 | 2017 | 134 | 0.310 |
Why?
|
| Plaque, Amyloid | 4 | 2017 | 29 | 0.310 |
Why?
|
| Literacy | 2 | 2021 | 9 | 0.290 |
Why?
|
| Sclerosis | 3 | 2019 | 26 | 0.290 |
Why?
|
| Cross-Sectional Studies | 6 | 2022 | 203 | 0.290 |
Why?
|
| Antioxidants | 3 | 2005 | 22 | 0.280 |
Why?
|
| Feeding Behavior | 2 | 2005 | 25 | 0.270 |
Why?
|
| Dietary Fats | 2 | 2006 | 19 | 0.250 |
Why?
|
| Vitamin E | 3 | 2005 | 17 | 0.250 |
Why?
|
| Language Tests | 1 | 2006 | 6 | 0.250 |
Why?
|
| Intelligence | 1 | 2006 | 8 | 0.250 |
Why?
|
| Death | 2 | 2021 | 11 | 0.250 |
Why?
|
| Logistic Models | 6 | 2017 | 109 | 0.250 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2017 | 20 | 0.250 |
Why?
|
| Smell | 2 | 2016 | 8 | 0.240 |
Why?
|
| Personality Disorders | 1 | 2006 | 3 | 0.240 |
Why?
|
| Child Abuse | 1 | 2006 | 5 | 0.240 |
Why?
|
| Awareness | 2 | 2016 | 13 | 0.240 |
Why?
|
| Neurotic Disorders | 1 | 2005 | 1 | 0.230 |
Why?
|
| Delusions | 1 | 2005 | 3 | 0.230 |
Why?
|
| Hallucinations | 1 | 2005 | 9 | 0.230 |
Why?
|
| Fish Products | 1 | 2005 | 2 | 0.230 |
Why?
|
| Fishes | 1 | 2005 | 2 | 0.230 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 187 | 0.230 |
Why?
|
| Genotype | 9 | 2017 | 114 | 0.230 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2006 | 54 | 0.230 |
Why?
|
| Life | 1 | 2005 | 2 | 0.230 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2015 | 28 | 0.230 |
Why?
|
| Social Class | 1 | 2005 | 12 | 0.220 |
Why?
|
| Lipids | 1 | 2025 | 15 | 0.220 |
Why?
|
| Time Factors | 5 | 2017 | 374 | 0.220 |
Why?
|
| Diet Surveys | 2 | 2006 | 9 | 0.220 |
Why?
|
| Air Pollutants | 1 | 2024 | 5 | 0.220 |
Why?
|
| Environmental Exposure | 1 | 2024 | 6 | 0.220 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.220 |
Why?
|
| Air Pollution | 1 | 2024 | 8 | 0.220 |
Why?
|
| Particulate Matter | 1 | 2024 | 8 | 0.220 |
Why?
|
| Sex Factors | 4 | 2016 | 129 | 0.210 |
Why?
|
| Surveys and Questionnaires | 7 | 2016 | 284 | 0.210 |
Why?
|
| Nutrition Disorders | 1 | 2003 | 2 | 0.210 |
Why?
|
| Life Change Events | 2 | 2014 | 12 | 0.200 |
Why?
|
| Cerebral Infarction | 3 | 2015 | 29 | 0.200 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2016 | 64 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2016 | 72 | 0.200 |
Why?
|
| Carotenoids | 1 | 2002 | 5 | 0.190 |
Why?
|
| Vitamin A | 1 | 2002 | 3 | 0.190 |
Why?
|
| Crime Victims | 1 | 2022 | 9 | 0.180 |
Why?
|
| Disability Evaluation | 5 | 2015 | 60 | 0.180 |
Why?
|
| Risk Assessment | 5 | 2018 | 112 | 0.180 |
Why?
|
| Hypertension | 1 | 2022 | 35 | 0.180 |
Why?
|
| Metacognition | 1 | 2021 | 3 | 0.180 |
Why?
|
| Diabetes Complications | 2 | 2016 | 15 | 0.180 |
Why?
|
| Adult | 5 | 2015 | 1670 | 0.170 |
Why?
|
| Alleles | 6 | 2016 | 89 | 0.170 |
Why?
|
| Social Discrimination | 1 | 2021 | 5 | 0.170 |
Why?
|
| Music | 1 | 2021 | 8 | 0.170 |
Why?
|
| Linear Models | 6 | 2017 | 64 | 0.160 |
Why?
|
| Tissue Donors | 1 | 2020 | 28 | 0.160 |
Why?
|
| Comorbidity | 4 | 2018 | 98 | 0.160 |
Why?
|
| Substantia Nigra | 2 | 2013 | 25 | 0.160 |
Why?
|
| Neuropathology | 2 | 2017 | 17 | 0.160 |
Why?
|
| Neoplasms | 2 | 2018 | 39 | 0.150 |
Why?
|
| Statistics, Nonparametric | 3 | 2015 | 28 | 0.150 |
Why?
|
| Neurocognitive Disorders | 1 | 2019 | 9 | 0.150 |
Why?
|
| Mental Status Schedule | 4 | 2017 | 32 | 0.150 |
Why?
|
| Disabled Persons | 2 | 2012 | 24 | 0.150 |
Why?
|
| Emergencies | 1 | 2019 | 18 | 0.140 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 4 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 21 | 0.140 |
Why?
|
| Osteoporosis | 1 | 2018 | 33 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 23 | 0.140 |
Why?
|
| Mobility Limitation | 2 | 2015 | 16 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 24 | 0.130 |
Why?
|
| Gene Expression | 1 | 2018 | 64 | 0.130 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 7 | 0.130 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 36 | 0.130 |
Why?
|
| Models, Statistical | 2 | 2016 | 36 | 0.130 |
Why?
|
| Reproducibility of Results | 3 | 2012 | 163 | 0.130 |
Why?
|
| Haplotypes | 1 | 2017 | 19 | 0.130 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 26 | 0.130 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 5 | 0.130 |
Why?
|
| Homozygote | 1 | 2017 | 6 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2017 | 23 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 77 | 0.120 |
Why?
|
| Personality Inventory | 2 | 2007 | 12 | 0.120 |
Why?
|
| Neuroticism | 1 | 2016 | 6 | 0.120 |
Why?
|
| Biostatistics | 1 | 2016 | 3 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2021 | 584 | 0.120 |
Why?
|
| Employment | 1 | 2016 | 13 | 0.120 |
Why?
|
| Brain Stem | 1 | 2016 | 6 | 0.120 |
Why?
|
| Social Adjustment | 2 | 2006 | 5 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 45 | 0.120 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2006 | 28 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 1 | 2015 | 15 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 36 | 0.120 |
Why?
|
| Copper | 2 | 2024 | 11 | 0.120 |
Why?
|
| Motor Disorders | 1 | 2015 | 4 | 0.110 |
Why?
|
| Health Status | 3 | 2019 | 47 | 0.110 |
Why?
|
| HIV Infections | 1 | 2017 | 135 | 0.110 |
Why?
|
| Psychometrics | 4 | 2012 | 52 | 0.110 |
Why?
|
| Reaction Time | 1 | 2015 | 39 | 0.110 |
Why?
|
| Empathy | 1 | 2014 | 8 | 0.110 |
Why?
|
| Mental Recall | 1 | 2014 | 14 | 0.110 |
Why?
|
| Quality of Life | 1 | 2015 | 108 | 0.100 |
Why?
|
| Raphe Nuclei | 1 | 2013 | 5 | 0.100 |
Why?
|
| Locus Coeruleus | 1 | 2013 | 6 | 0.100 |
Why?
|
| Ventral Tegmental Area | 1 | 2013 | 6 | 0.100 |
Why?
|
| Cell Count | 1 | 2013 | 16 | 0.100 |
Why?
|
| Models, Psychological | 2 | 2015 | 11 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2013 | 17 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2017 | 60 | 0.090 |
Why?
|
| Anomie | 1 | 2012 | 2 | 0.090 |
Why?
|
| Social Environment | 1 | 2012 | 9 | 0.090 |
Why?
|
| Statistics as Topic | 2 | 2017 | 22 | 0.090 |
Why?
|
| Social Behavior | 2 | 2009 | 13 | 0.090 |
Why?
|
| Corticosterone | 1 | 2011 | 1 | 0.090 |
Why?
|
| Guanylate Kinases | 1 | 2011 | 1 | 0.090 |
Why?
|
| Post-Synaptic Density | 1 | 2011 | 1 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 15 | 0.080 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 5 | 0.080 |
Why?
|
| Receptors, Complement 3b | 1 | 2011 | 8 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2011 | 38 | 0.080 |
Why?
|
| Psychomotor Performance | 2 | 2015 | 48 | 0.080 |
Why?
|
| Brazil | 2 | 2021 | 10 | 0.080 |
Why?
|
| Wechsler Scales | 2 | 2010 | 4 | 0.080 |
Why?
|
| Frail Elderly | 1 | 2010 | 4 | 0.080 |
Why?
|
| Genetic Association Studies | 3 | 2017 | 32 | 0.080 |
Why?
|
| Heterozygote | 2 | 2025 | 59 | 0.080 |
Why?
|
| Interviews as Topic | 2 | 2021 | 44 | 0.080 |
Why?
|
| Diet, Mediterranean | 1 | 2010 | 19 | 0.080 |
Why?
|
| Self Care | 1 | 2010 | 28 | 0.080 |
Why?
|
| Mental Status and Dementia Tests | 2 | 2021 | 16 | 0.080 |
Why?
|
| Child | 2 | 2012 | 339 | 0.080 |
Why?
|
| Self Report | 2 | 2022 | 53 | 0.070 |
Why?
|
| Population Surveillance | 2 | 2015 | 20 | 0.070 |
Why?
|
| Sex Characteristics | 2 | 2022 | 36 | 0.070 |
Why?
|
| Muscle Strength | 1 | 2009 | 23 | 0.070 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2005 | 8 | 0.070 |
Why?
|
| Clergy | 2 | 2005 | 13 | 0.070 |
Why?
|
| Prognosis | 2 | 2018 | 138 | 0.070 |
Why?
|
| Muscle Rigidity | 1 | 2006 | 2 | 0.060 |
Why?
|
| Latin America | 1 | 2006 | 1 | 0.060 |
Why?
|
| Dyskinesias | 1 | 2006 | 3 | 0.060 |
Why?
|
| Medicare | 2 | 2019 | 30 | 0.060 |
Why?
|
| Likelihood Functions | 2 | 2017 | 9 | 0.060 |
Why?
|
| Trans Fatty Acids | 1 | 2006 | 4 | 0.060 |
Why?
|
| Confidence Intervals | 3 | 2017 | 22 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2006 | 13 | 0.060 |
Why?
|
| Animals | 2 | 2011 | 1349 | 0.060 |
Why?
|
| Illinois | 2 | 2017 | 52 | 0.060 |
Why?
|
| Psychology | 1 | 2006 | 5 | 0.060 |
Why?
|
| Parenting | 1 | 2006 | 7 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2006 | 4 | 0.060 |
Why?
|
| Parents | 1 | 2006 | 19 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 66 | 0.060 |
Why?
|
| Longevity | 1 | 2005 | 4 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2005 | 37 | 0.060 |
Why?
|
| Sleep | 1 | 2006 | 88 | 0.060 |
Why?
|
| Energy Intake | 1 | 2005 | 36 | 0.060 |
Why?
|
| Eating | 1 | 2005 | 16 | 0.060 |
Why?
|
| Family Characteristics | 1 | 2005 | 4 | 0.060 |
Why?
|
| Triglycerides | 1 | 2025 | 15 | 0.060 |
Why?
|
| Tocopherols | 1 | 2005 | 3 | 0.060 |
Why?
|
| Cholesterol | 1 | 2025 | 21 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 100 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.050 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.050 |
Why?
|
| Zinc | 1 | 2024 | 12 | 0.050 |
Why?
|
| Prejudice | 1 | 2004 | 9 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 71 | 0.050 |
Why?
|
| Residence Characteristics | 2 | 2015 | 43 | 0.050 |
Why?
|
| Seafood | 1 | 2003 | 6 | 0.050 |
Why?
|
| Age of Onset | 2 | 2013 | 27 | 0.050 |
Why?
|
| Fraud | 1 | 2022 | 6 | 0.050 |
Why?
|
| Psychological Tests | 1 | 2002 | 7 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2022 | 48 | 0.050 |
Why?
|
| Executive Function | 1 | 2021 | 31 | 0.040 |
Why?
|
| Mathematics | 1 | 2021 | 25 | 0.040 |
Why?
|
| Writing | 1 | 2021 | 9 | 0.040 |
Why?
|
| Attitude to Death | 1 | 2020 | 4 | 0.040 |
Why?
|
| Tissue and Organ Procurement | 1 | 2020 | 12 | 0.040 |
Why?
|
| Health Behavior | 1 | 2020 | 42 | 0.040 |
Why?
|
| Nutrition Assessment | 3 | 2005 | 18 | 0.040 |
Why?
|
| Income | 1 | 2019 | 3 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2018 | 78 | 0.040 |
Why?
|
| Prevalence | 1 | 2018 | 72 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 38 | 0.030 |
Why?
|
| Dementia, Vascular | 1 | 2018 | 7 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 141 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 7 | 0.030 |
Why?
|
| Diagnosis | 1 | 2017 | 5 | 0.030 |
Why?
|
| Inflammation | 1 | 2018 | 53 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 6 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 5 | 0.030 |
Why?
|
| tau Proteins | 1 | 2017 | 36 | 0.030 |
Why?
|
| Arteriolosclerosis | 1 | 2016 | 14 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 16 | 0.030 |
Why?
|
| Brain Infarction | 1 | 2016 | 23 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 18 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 16 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 25 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 46 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 54 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 14 | 0.030 |
Why?
|
| Mental Health | 1 | 2016 | 16 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2016 | 111 | 0.030 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 4 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 10 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 207 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 54 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2014 | 5 | 0.030 |
Why?
|
| Intelligence Tests | 1 | 2014 | 7 | 0.030 |
Why?
|
| Dietary Supplements | 2 | 2005 | 18 | 0.030 |
Why?
|
| Life Style | 1 | 2014 | 48 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 67 | 0.020 |
Why?
|
| Multilevel Analysis | 1 | 2012 | 4 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2012 | 13 | 0.020 |
Why?
|
| Disks Large Homolog 4 Protein | 1 | 2011 | 2 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 35 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 57 | 0.020 |
Why?
|
| Wine | 1 | 2010 | 2 | 0.020 |
Why?
|
| Nutrition Policy | 1 | 2010 | 6 | 0.020 |
Why?
|
| Trail Making Test | 1 | 2010 | 3 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2010 | 3 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2010 | 35 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 122 | 0.020 |
Why?
|
| Young Adult | 1 | 2012 | 421 | 0.020 |
Why?
|
| Adolescent | 1 | 2012 | 488 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 125 | 0.020 |
Why?
|
| Mice | 1 | 2011 | 465 | 0.020 |
Why?
|
| Social Support | 1 | 2009 | 39 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2006 | 8 | 0.020 |
Why?
|
| alpha-Tocopherol | 1 | 2005 | 3 | 0.010 |
Why?
|
| gamma-Tocopherol | 1 | 2005 | 3 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2003 | 4 | 0.010 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2003 | 4 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 2003 | 4 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2003 | 9 | 0.010 |
Why?
|
| beta Carotene | 1 | 2002 | 5 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2002 | 15 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 23 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2002 | 25 | 0.010 |
Why?
|